Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Stockholders Equity of $107.54 million for fiscal year 2025.
LEXICON PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $107.54M | -26.3% |
| 2024 | $145.95M | +56.8% |
| 2023 | $93.11M | -20.5% |
| 2022 | $117.12M | +3.1% |
| 2021 | $113.59M | -27.4% |
| 2020 | $156.37M | +33.5% |
| 2019 | $117.10M | +543.5% |
| 2018 | -$26.41M | -138.7% |
| 2017 | $68.27M | -59.2% |
| 2016 | $167.51M | -41.4% |
| 2015 | $285.97M | +0.7% |
| 2014 | $284.02M | +66.9% |
| 2013 | $170.16M | -36.2% |
| 2012 | $266.68M | -10.4% |
| 2011 | $297.57M | +20.5% |
| 2010 | $247.02M | +51.1% |
| 2009 | $163.50M | -16.5% |
| 2008 | $195.83M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $120.16M | -32.7% | -7.2% |
| June 30, 2025 | $129.44M | -46.1% | +5.2% |
| March 31, 2025 | $123.03M | -57.4% | -15.7% |
| December 31, 2024 | $145.95M | +56.8% | -18.2% |
| September 30, 2024 | $178.51M | +28.0% | -25.6% |
| June 30, 2024 | $239.98M | +28.8% | -16.9% |
| March 31, 2024 | $288.87M | +228.1% | +210.2% |
| December 31, 2023 | $93.11M | -20.5% | -33.3% |
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -26.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, LEXICON PHARMACEUTICALS, INC.’s stockholders equity has declined by 45.1% (from $195.83 million to $107.54 million).
- The most recent figure is from LEXICON PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: